Merit Medical Systems, Inc. (MMSI)
86.63
-0.06
(-0.07%)
USD |
NASDAQ |
Nov 13, 16:00
86.62
-0.01
(-0.01%)
After-Hours: 19:59
Merit Medical Systems Enterprise Value : 5.505B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.505B |
| November 12, 2026 | 5.509B |
| November 11, 2026 | 5.591B |
| November 10, 2026 | 5.576B |
| November 09, 2026 | 5.612B |
| November 06, 2026 | 5.541B |
| November 05, 2026 | 5.684B |
| November 04, 2026 | 5.745B |
| November 03, 2026 | 5.357B |
| November 02, 2026 | 5.366B |
| October 30, 2026 | 5.482B |
| October 29, 2026 | 5.910B |
| October 28, 2026 | 5.839B |
| October 27, 2026 | 5.919B |
| October 26, 2026 | 5.959B |
| October 23, 2026 | 5.905B |
| October 22, 2026 | 5.943B |
| October 21, 2026 | 5.791B |
| October 20, 2026 | 5.778B |
| October 19, 2026 | 5.705B |
| October 16, 2026 | 5.659B |
| October 15, 2026 | 5.681B |
| October 14, 2026 | 5.537B |
| October 13, 2026 | 5.596B |
| October 12, 2026 | 5.692B |
| Date | Value |
|---|---|
| October 09, 2026 | 5.540B |
| October 08, 2026 | 5.423B |
| October 07, 2026 | 5.413B |
| October 06, 2026 | 5.405B |
| October 05, 2026 | 5.536B |
| October 02, 2026 | 5.430B |
| October 01, 2026 | 5.476B |
| September 30, 2026 | 5.481B |
| September 29, 2026 | 5.616B |
| September 28, 2026 | 5.564B |
| September 25, 2026 | 5.594B |
| September 24, 2026 | 5.582B |
| September 23, 2026 | 5.568B |
| September 22, 2026 | 5.580B |
| September 21, 2026 | 5.474B |
| September 18, 2026 | 5.467B |
| September 17, 2026 | 5.479B |
| September 16, 2026 | 5.513B |
| September 15, 2026 | 5.515B |
| September 14, 2026 | 5.565B |
| September 11, 2026 | 5.526B |
| September 10, 2026 | 5.532B |
| September 09, 2026 | 5.575B |
| September 08, 2026 | 5.587B |
| September 04, 2026 | 5.719B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.161B |
| Glaukos Corp. | 14.30B |
| Becton, Dickinson & Co. | 74.72B |
| DexCom, Inc. | 30.66B |
| Haemonetics Corp. | 6.460B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 42.31M |
| Revenue (Quarterly) | 416.89M |
| Total Expenses (Quarterly) | 374.58M |
| EPS Diluted (Quarterly) | 0.7008 |
| Gross Profit Margin (Quarterly) | 48.53% |
| Profit Margin (Quarterly) | 10.15% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 4.20% |
| Normalized Earnings Yield | 3.157 |